Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation (NCT03728335)

🔬

Loading study...

Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation (NCT03728335) | TrialReferrals